Quarterly Financial Data

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]



	2019
	1st		2nd		3rd		4th		Total
Net sales	$	979.7	$	1,000.0	$	914.0	$	896.2	$	3,789.9
Gross profit	302.6		305.7		277.5		256.0		1,141.8
Selling, general and administrative expenses	152.7		158.7		148.0		159.2		618.6
Impairment and restructuring charges	—		1.9		1.6		3.3		6.8
Net income ⁽¹⁾	95.3		94.9		66.7		117.8		374.7
Net income attributable to noncontrolling interests	3.4		2.4		2.5		4.3		12.6
Net income attributable to The Timken Company	91.9		92.5		64.2		113.5		362.1
Net income per share - Basic:	$	1.21	$	1.22	$	0.85	$	1.51	$	4.78
Net income per share - Diluted:	$	1.19	$	1.20	$	0.84	$	1.48	$	4.71
Dividends per share	$	0.28	$	0.28	$	0.28	$	0.28	$	1.12

	2018
	1st		2nd		3rd		4th		Total
Net sales	$	883.1	$	906.3	$	881.3	$	910.1	$	3,580.8
Gross profit	264.9		267.4		253.3		254.5		1,040.1
Selling, general and administrative expenses	148.6		141.8		142.0		148.3		580.7
Impairment and restructuring charges	0.2		0.3		2.6		1.8		4.9
Net income ⁽²⁾	80.5		91.9		72.3		60.8		305.5
Net income attributable to noncontrolling interests	0.3		0.9		0.7		0.8		2.7
Net income attributable to The Timken Company	80.2		91.0		71.6		60.0		302.8
Net income per share - Basic:	$	1.03	$	1.18	$	0.93	$	0.78	$	3.93
Net income per share - Diluted:	$	1.02	$	1.16	$	0.91	$	0.77	$	3.86
Dividends per share	$	0.27	$	0.28	$	0.28	$	0.28	$	1.11

Earnings per share are computed independently for each of the quarters presented; therefore, the sum of the quarterly earnings per share may not equal the total computed for the year.


(1)	Net income for the third quarter of 2019 included net actuarial losses of $16.9 million. Net income for the fourth quarter of 2019 included the reversal of tax valuation allowances of $44.5 million and net actuarial gains of $21.1 million.

(2)

Net income for the fourth quarter of 2018 included net actuarial losses of $19.7 million, partially offset by curtailment gains of $10.2 million.